نتائج البحث

Safety, Tolerability, and Bioeffects of Alirocumab in Non-treatment Seeking Heavy Drinkers

• Source: A Phase I, Randomized, Double-Blind, Placebo-Controlled, Study of Safety, Tolerability, and Bioeffects of Alirocumab in Non-treatment Seeking Heavy Drinkers

تفاصيل العنوان

Cardiac Allograft Vasculopathy Inhibition with Alirocumab (CAVIAR)

• Authors : National Heart, Lung, and Blood Institute (NHLBI); William Fearon, Professor, Cardiovascular Medicine

• Source: PCSK9 Inhibition After Heart Transplantation

تفاصيل العنوان

Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation

• Authors : Goodman, Shaun G; Steg, Philippe Gabriel; Szarek, Michael

Subjects: Biomedical and Clinical Sciences; Clinical Sciences; Clinical Trials and Supportive Activities

• Source: European Heart Journal - Cardiovascular Pharmacotherapy. 10(4)

تفاصيل العنوان

Alirocumab in Patients With Sepsis (PALMS)

• Authors : Regeneron Pharmaceuticals; Jonathan Sevransky, Professor

• Source: PCSK9 and Lipid Metabolism in Sepsis (PALMS) : A Two-center, Phase 1b Randomized, Placebo-controlled, Double-blind, Clinical Trial of Alirocumab in Patients With Sepsis

تفاصيل العنوان

Gene Mutation in Patients with Familial Hypercholesterolemia and Response to Alirocumab Treatment—A Single-Centre Analysis.

• Authors : Rogozik, Joanna¹ (AUTHOR) ; Rokicki, Jakub Kosma^1,2 (AUTHOR); Grabowski, Marcin¹ (AUTHOR)

• Source: Journal of Clinical Medicine. Sep2024, Vol. 13 Issue 18, p5615. 15p.

تفاصيل العنوان

Extra Alirocumab in Addition to Statin Therapy in Asymptomatic Intracranial Atherosclerotic Stenosis (EAST-aICAS) (EAST-aICAS)

• Authors : Kezhong Zhang, Professor

• Source: Extra Alirocumab in Addition to Statin Therapy in Asymptomatic Intracranial Atherosclerotic Stenosis (EAST-aICAS)----a Pilot StudyHolmstedt CA, Turan TN, Chimowitz

تفاصيل العنوان

阿利西尤单抗联用海博麦布对急性ST段 抬高型心肌梗死的疗效.

• Authors : 董耀辉¹; 王晓慧¹; 胡钢¹

• Source: Journal of Practical Medicine / Shiyong Yixue Zazhi. 5/10/2024, Vol. 40 Issue 9, p1298-1302. 5p.

تفاصيل العنوان

Efficacy and Safety Of Alirocumab to Prevent Early Cardiac Allograft Vasculopathy in Recent Heart Transplant Recipients (ACAV)

• Authors : Vojtech Melenovsky, MD, PhD, Deputy director of the Research Department, senior consultant of the Heart Failure Division

• Source: ACAV: Efficacy and Safety Of Alirocumab to Prevent Early Cardiac Allograft Vasculopathy in Recent Heart Transplant RecipientsChen Z, Pazdernik M, Zhang H, Wahle A,

تفاصيل العنوان

Extra Alirocumab in Addition to Statin Therapy in Symptomatic IntraCranial Atherosclerotic Stenosis ----a Pilot Study (EAST-sICAS)

• Authors : Kezhong Zhang, Professor

• Source: Extra Alirocumab in Addition to Statin Therapy in Symptomatic IntraCranial Atherosclerotic Stenosis ----a Pilot StudyHolmstedt CA, Turan TN, Chimowitz MI.

تفاصيل العنوان

Quantitative assessment of baseline imbalances in evolocumab and alirocumab trials: a meta-epidemiological study.

• Authors : van Bruggen, F. H.¹ (AUTHOR); Zuidema, S. U.¹ (AUTHOR); Luijendijk, H. J.¹ (AUTHOR)

• Source: BMC Medical Research Methodology. 6/22/2024, Vol. 24 Issue 1, p1-13. 13p.

تفاصيل العنوان